Characteristics of Adult Patients With Atopic Dermatitis Initiating Biologics and Janus Kinase Inhibitors in the CorEvitas Atopic Dermatitis Registry

ABSTRACT Background Biologics and Janus kinase inhibitors (JAKi) are two advanced systemic treatment options for patients with atopic dermatitis (AD). The decision to initiate one of these therapies is complex and may be driven by many factors. Objectives This cross‐sectional study described and eva...

Description complète

Détails bibliographiques

Auteurs principaux:	Eric L. Simpson, Linda Stein Gold, Seemal R. Desai, Alexandra K. Golant, Douglas DiRuggiero, Christian Fenske, Yolanda Muñoz Maldonado, Alvin H. Li, Zach Dawson, Kaylee Ho, Kayla Callahan, Gaia Gallo, Jonathan I. Silverberg
Format:	Artigo
Langue:	Inglês
Publié:	Wiley 2026-03-01
Collection:	JEADV Clinical Practice
Sujets:	atopic dermatitis biologics JAK inhibitors real‐world evidence
Accès en ligne:	https://doi.org/10.1002/jvc2.70153
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!